Piceatannol
CAS 10083-24-6
Piceatannol (CAS 10083-24-6) is a pharmaceutical compound with 9 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 18111.89419354839 nM | 109 | - |
| - | GI50 | 16004.900689655173 nM | 58 | - |
| - | IC50 | 24063.954901960784 nM | 51 | - |
| - | EC50 | 46000 nM | 10 | - |
| - | Ki | 6713.75 nM | 8 | - |
| - | AC50 | 10290.75 nM | 4 | - |
| - | IC50 | 12.25 ug.mL-1 | 4 | - |
| - | Kd | 4945 nM | 4 | - |
| - | MIC | 337.5 ug.mL-1 | 4 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Piceatannol used for in pharmaceutical contexts?
Piceatannol (CAS 10083-24-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Piceatannol?
No adverse-event association or SIDER side-effect rows are rendered for Piceatannol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Piceatannol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Piceatannol with EU status "permitted".
What clinical phase is Piceatannol in?
No phase 1-4 clinical development badge is rendered for Piceatannol because the matched compound identifier rows do not contain a max-phase value.